MedPath

To know The Combined Effect Of Amrutadya Guggulu And Udvartana Followed By Bashpa Sweda In Obesity

Not Applicable
Conditions
Health Condition 1: E663- Overweight
Registration Number
CTRI/2023/03/050502
Lead Sponsor
Dr Payal V Chavat
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.BMI- 25 to 35 kg/m2

2.Chalaspika, udar, stahan

3.Swedadhikya

4.Kshudha adhikya

5.Pipasa adhikya

6.Kshudra Shwasa

7.Nidra adhikya

Exclusion Criteria

1.Pregnant, lactating women, Women on oral contraceptive

2.Known case of Uncontrolled Diabetes with its complications, Hypothyroidism, Cardiovascular, Renal disorders and Drug induced Obesity.

3.Known case of acute complications like CHD, Hepatitis.

4.Known cases of Major systemic diseases such as AIDS, IHD, Carcinoma, Renal and Cerebral diseases.

5.Subject suffering from any skin lesion over fatty area

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the difference in BMI, Lipid profile, Anthropometric parameters after combined use of Amrutadya Guggulu and Udvartana followed by bashpa sweda for 37 days in the management Of Sthaulya.Timepoint: 37 days with follow up on 7th, 22nd, 37th day
Secondary Outcome Measures
NameTimeMethod
To evaluate the combined efficacy of Amrutadya Guggulu and Udvartana followed by bashpa sweda over antropometric parameters i.e Abdominal circumference, Mid arm circumference, mid thigh circumference, chest circumference, Hip circumference <br/ ><br>2. To evaluate the combined efficacy of Amrutadya Guggulu and Udvartana followed by bashpa sweda over Serum lipid profile. <br/ ><br>3.To study the disease Sthaulya according to Ayurveda & modern view.Timepoint: 37 days with follow up on 7th, 22nd, 37th day
© Copyright 2025. All Rights Reserved by MedPath